Pharmacokinetics linearity [Regulatives / Guidelines]

posted by pjs – India, 2015-05-28 18:11 (4046 d 15:12 ago) – Posting: # 14875
Views: 5,412

Dear nobody,

Apologies for the wrong terminology. What i mean to say was extrapolating the linearity on lower range. I also had doubts regarding this option as mentioned in my earlier post. But just wanted to know forum members view on that.

Apart from point 3 of earlier post would like to know view about the 1st and 2nd point of the forum members.

Has any body experinece in filling generic product in which similar extrapolation of the linearity has been done and accepted by the agency.

Thanks.

Regards,
PJS

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
164 visitors (0 registered, 164 guests [including 39 identified bots]).
Forum time: 09:24 CEST (Europe/Vienna)

Ignorance more frequently begets confidence
than does knowledge.    Charles Darwin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5